Prostate Cancer Trial, Recruiting NCT04556916 Sponsor: University Hospital, Montpellier Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT04556916
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

As a Patient Participant:

  • You are a man aged 41 or older who is suspected of possibly having prostate cancer
  • Your PSA blood test result is 4 or higher and your doctor has recommended a prostate biopsy
  • You are able to attend all required appointments and follow the trial procedures
  • You have already had a special type of prostate MRI scan before your biopsy
  • You are covered by public health insurance
  • You are willing and able to sign a consent form agreeing to take part

As a Control (Healthy) Participant:

  • You are a man aged 41 or older with no suspicion of prostate cancer
  • Your PSA blood test result is below 2.5 and your physical prostate examination was normal
  • You are covered by public health insurance
  • You are willing and able to sign a consent form agreeing to take part

Who may not be able to join:

As a Patient Participant:

  • You have already been diagnosed with prostate cancer through a biopsy
  • You have a confirmed HIV or Hepatitis infection
  • You are currently taking a medication called Finasteride
  • You are currently on any hormonal treatment related to prostate conditions
  • You have been diagnosed with another type of cancer
  • You are unable to sign the consent form
  • You have plans to be away from the area for an extended period that would prevent you from attending appointments
  • You are in a situation where your freedom or decision-making ability is restricted (confirm with trial site)
  • You have had a urinary infection within the last 2 months
  • You are not registered with public health insurance
  • You are unwilling to have a prostate biopsy
  • You work for or are in a dependent relationship with the organisation running the trial

As a Control (Healthy) Participant:

  • You have already been diagnosed with prostate cancer through a biopsy
  • You have a confirmed HIV or Hepatitis infection
  • You are currently taking a medication called Finasteride
  • You have been diagnosed with another type of cancer
  • You are unable to sign the consent form
  • You have plans to be away from the area for an extended period that would prevent you from attending appointments
  • You are in a situation where your freedom or decision-making ability is restricted (confirm with trial site)
  • You have had a urinary infection within the last 2 months
  • You are not registered with public health insurance

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Catherine ALIX-PANABIERES, MCU-PH, University Hospital, Montpellier

Phone: +33 4 11 75 99 31

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 February 2021
Est. completion
15 November 2023

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Discovery of CTCs and tumour cell products circulating in blood (DNA, exosomes) for early PCa detection.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov